ResMed, Australia's largest manufacturer and exporter of medical respiratory devices, has renewed its license to Objective Corporation's knowledge and process management solution. [ + ]

A new council has been established to advise the Commonwealth government on priority issues in biotechnology, including R&D, international links, commercialisation, public interest and ethics. [ + ]

Long-term dairy research projects with the potential to contribute to the Victorian economy will have a chance at financial backing worth $1.25 million over five years. [ + ]

Establishing corporate governance from the outset is vital for a company to succeed. The process for companies managing research biohubs, however, has become a lot more complex and time-consuming, according to Adam Liberman, a partner at law firm Freehills. [ + ]

Sydney-based biotech Gradipore is adapting its Gradiflow technology to help treat patients with kidney failure. [ + ]

Amrad Corporation has confirmed a general meeting will be held on May 22 to resolve a board dispute with its major shareholder, Fibre Optics. [ + ]

Clinical trials have validated the efficacy of a new test kit for diagnosis of systemic candidiasis, developed by Perth company Rockeby Biomed. [ + ]

Two of the three annual awards made by the Australian Society of Biochemistry and Molecular Biology have gone to staff of the ANU this year.

Peptech's worldwide hunt for a new CEO has been abandoned after three of the board members, including its Chairman Dr Ed Tweddell, walked out of the company last week under pressure from angry shareholders. [ + ]

Genetic Technologies has announced a licence agreement with Nanogen, following the company's agreement last week with US company Sequenom. [ + ]

Australia's Grains Research and Development Corporation (GRDC) is in line to become one of the first commercial organisations licensed to use Syngenta's rice genome sequence. [ + ]

A senior immunologist and kidney specialist has been accused of committing serious scientific misconduct and misspending public funds from the National Health and Medical Research Council. [ + ]

Applicants for the Federal government's Biotechnology Centre of Excellence were today whittled down to four. [ + ]

The new nuclear reactor at Lucas Heights, in Sydney, will give Australian medical researchers access to the latest therapeutic radioisotopes, according to the head of the facility's radioisotope manufacturing arm. [ + ]

Start-up biotechnology companies in NSW are to receive support through a new $2.5 million project. [ + ]